Publication | Closed Access
Treatment of Infections in Patients with the Acquired Immunodeficiency Syndrome
239
Citations
14
References
1985
Year
InfectionImmunologyPathologyImmunotherapyInfection ControlHealth SciencesPrimary ImmunodeficiencyNeurovirologyVirologyChronic Viral InfectionHivAcquired Immunodeficiency SyndromeClinical MicrobiologyToxoplasma GondiiAntibioticsTreatment And PreventionPathogenesisClinical InfectionCentral Nervous SystemMedicine
Patients with AIDS are frequently infected by a range of opportunistic microorganisms that exploit T‑cell, B‑cell, or other immune defects, including common pathogens such as Pneumocystis carinii, cytomegalovirus, Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Shigella species, and hospital‑associated organisms, with many infections recurring after treatment cessation and often requiring prolonged therapy. Postmortem examination revealed disseminated Mycobacterium avium‑intracellulare infection in half of the studied AIDS patients.
The microorganisms that regularly infect patients with the acquired immunodeficiency syndrome (AIDS) have become well recognized. Most take advantage of defects in T-lymphocyte function, but others, such as Streptococcus pneumoniae and Haemophilus influenzae, take advantage of B-cell defects. Still others, such as Staphylococcus aureus and Shigella species, occur or persist for reasons that are unclear. Infections with organisms associated with hospitalization and medical procedures are also seen and should be anticipated. Among the infections taking advantage of T-cell defects, Pneumocystis carinii pneumonia is the most commonly diagnosed, but cytomegalovirus infection may be equally common. Disseminated Mycobacterium avium-intracellulare infection has been found in one half of our patients at postmortem examination. The retrovirus responsible for AIDS commonly infects the central nervous system, as does Toxoplasma gondii. Although candida infections are common, dissemination is uncommon. Many of the infections respond to appropriate therapy but tend to recur when treatment is stopped. Often treatment courses must be prolonged even beyond those used in other immunocompromised hosts.
| Year | Citations | |
|---|---|---|
Page 1
Page 1